"
Team:ITESM Mexico/Safety
From 2011.igem.org
(Difference between revisions)
(Prototype team page) |
|||
| (51 intermediate revisions not shown) | |||
| Line 1: | Line 1: | ||
| - | + | {{Team:ITESM_Mexico/Top}} | |
| - | <html> | + | <html><h1 class="myowntitle">Safety</h1> </html> |
| - | < | + | ---- |
| - | < | + | |
| - | + | ||
| - | </ | + | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | [[File:Biosecurity 2.jpg|300px|center]] | |
| - | + | # '''Would any of your project ideas raise safety issues in terms of:''' | |
| - | + | #;* researcher safety, | |
| - | + | #;* public safety, or | |
| - | + | #;* environmental safety? | |
| - | + | #: | |
| - | + | #: Our Project works with (''Escherichia coli'') strains DH5-alpha and BW27783 which are non-pathogenic, nor iharmful to plants, animals or human beings. Nonetheless every broth, agar and material involved in the culturing of the bacteria is autoclaved and disposed along the guidelines of standard biosecurity residues procedures. | |
| - | '' | + | #: With a fully-characterized recombinant organism (a clone of ''E. coli'' K12, for instance), there is no reason to think that the hazard will be any more than indicated by the insert and its product. The risk assessment will then simply be a consideration of the extent of expression of the insert and the chance of damage caused by the product of such expression (Tzotzos, 1995). |
| - | + | #: The microorganism that we will be working with belongs to Hazard Group 1 which means is unlikely to cause a human disease, and so we can say we are working in Biosafety level 1. | |
| - | + | #: | |
| - | + | #: | |
| - | + | #: | |
| - | + | #: | |
| - | + | #: | |
| - | + | #: | |
| - | + | #: | |
| - | + | # '''Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,''' | |
| - | + | #;* did you document these issues in the Registry? | |
| - | + | #;* how did you manage to handle the safety issue? | |
| - | + | #;* How could other teams learn from your experience? | |
| - | + | #: | |
| - | + | #: Our new biobricks are devices created to stop and regulate the expression of non-essential genes. This means that they do not represent a risk due to the incapability of interfering with normal cell functions. They do not require a toxic component to operate and are designed to be implemented in an easily controlled bacterial environment that can be considered non harmful to humans. | |
| - | + | #: | |
| - | + | #: | |
| - | + | #: | |
| - | + | #: | |
| - | + | # '''Is there a local biosafety group, committee, or review board at your institution?''' | |
| - | + | #:Our university has no formal committee or biosafety group. The professors that are aiding us in the project follow standard rules and regulations in order to avoid biosecurity breaches. We have been trained in several classes to implement good-practice laboratory standards. Safety is a must at the laboratory, thus we have reviewed and practiced how to report and handle potential dangerous spills (say, ethidium bromide!) and other emergencies. The facilities in which we are working and developing the project have been designed according to international standards. In Mexico, we have two main institutes in charge of biosecurity: | |
| - | + | #: | |
| - | + | #: | |
| - | + | #:* InDRE (Instituto de Diagnóstico y Referencia Epidemiológicos) | |
| - | + | #:* CIBIOGEM (Comisión Intersecretarial de Bioseguridad de los Organismos Genéticamente Modificados) | |
| + | #: | ||
| + | #: However, the InDRE (regulated by CDC) does not produce enough manuals and information. That is why we decided to base our laboratory practices in accordance to World Health Organization (WHO) Laboratory Biosafety Manuals and the US government CDC manuals. Nevertheless, during the inauguration of the laboratories, they came to review the safety standards and there were no negative comments on any problems. We also had a Workshop from CDC in our laboratories, and they congratulated us because of the facilities' biosecurity measures and the set of rules that our teachers and tutors enforce during lab sessions. | ||
| + | #: | ||
| + | #: | ||
| + | #: | ||
| + | # '''Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?''' | ||
| + | #: | ||
| + | #: Many countries do not have proper biosafety protocols, and although many teams have not engaged potentially risky projects as the competition evolves and more BioBricks become available to future teams the challenges and hazards involved in the design of biomachines will surely increase; therefore this problem will gain even more significance. Preparedness is essential. | ||
| + | #:Taking this into consideration, it would be useful or even necessary to create a committee of biosafety for the iGEM competition that regulates all the procedures in the laboratory and evaluate the possible risks that projects may implicate. This safety protocols could be developed by the iGEM community, discussed and proposed to be used by competing teams. The development of this idea could help every competing team that does not count with appropriate organisms or supervisors regarding this area. | ||
| + | #:Biosafety engineering can contribute with the safety of parts, devices and systems if, in line with the interest of achieving a final product that reaches high quality standards, diverse procedures and practices were considered since their development in laboratories, for example those related with safety precautions, lab workers protection, assessment and managing, safe transportation of materials and substances, monitoring national/ international legislations, among others. It is relevant to consider the far-reaching concept of biosafety, which involves the use of tools and methods in order to guarantee a responsible use of biotechnology. Safety procedures must be included in every biotechnological development since its conception, so every person involved (enterprising people, regulatory organisms, and consumers), could acquire appropriate protocols. Biosafety engineering can be greatly helpful in the construction of safe projects, parts, devices and systems which will provide credibility, confidence; therefore the possibility of social acceptance and integration. | ||
| + | #: | ||
| + | '''References:''' | ||
| + | : | ||
| + | : | ||
| + | :* Tzotzos, G (1995). Genetically modified organisms: a guide to biosafety. International Centre for Genetic Engineering and Biotechnology, C.A.B. International | ||
| + | :* Centers for Disease Control and Prevention (2011). Biosafety: Publications and Forms. Retrieved from: http://www.cdc.gov/biosafety/publications/index.htm | ||
| + | :* World Health Organization (2011). International Health Regulations: Biosafety and Laboratory Security. Retrieved from: http://www.who.int/ihr/biosafety/en/ | ||
Latest revision as of 03:21, 29 September 2011
ITESM MÉXICO
SensE.coli
Safety
- Would any of your project ideas raise safety issues in terms of:
- researcher safety,
- public safety, or
- environmental safety?
- Our Project works with (Escherichia coli) strains DH5-alpha and BW27783 which are non-pathogenic, nor iharmful to plants, animals or human beings. Nonetheless every broth, agar and material involved in the culturing of the bacteria is autoclaved and disposed along the guidelines of standard biosecurity residues procedures.
- With a fully-characterized recombinant organism (a clone of E. coli K12, for instance), there is no reason to think that the hazard will be any more than indicated by the insert and its product. The risk assessment will then simply be a consideration of the extent of expression of the insert and the chance of damage caused by the product of such expression (Tzotzos, 1995).
- The microorganism that we will be working with belongs to Hazard Group 1 which means is unlikely to cause a human disease, and so we can say we are working in Biosafety level 1.
- Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,
- did you document these issues in the Registry?
- how did you manage to handle the safety issue?
- How could other teams learn from your experience?
- Our new biobricks are devices created to stop and regulate the expression of non-essential genes. This means that they do not represent a risk due to the incapability of interfering with normal cell functions. They do not require a toxic component to operate and are designed to be implemented in an easily controlled bacterial environment that can be considered non harmful to humans.
- Is there a local biosafety group, committee, or review board at your institution?
- Our university has no formal committee or biosafety group. The professors that are aiding us in the project follow standard rules and regulations in order to avoid biosecurity breaches. We have been trained in several classes to implement good-practice laboratory standards. Safety is a must at the laboratory, thus we have reviewed and practiced how to report and handle potential dangerous spills (say, ethidium bromide!) and other emergencies. The facilities in which we are working and developing the project have been designed according to international standards. In Mexico, we have two main institutes in charge of biosecurity:
-
- InDRE (Instituto de Diagnóstico y Referencia Epidemiológicos)
- CIBIOGEM (Comisión Intersecretarial de Bioseguridad de los Organismos Genéticamente Modificados)
- However, the InDRE (regulated by CDC) does not produce enough manuals and information. That is why we decided to base our laboratory practices in accordance to World Health Organization (WHO) Laboratory Biosafety Manuals and the US government CDC manuals. Nevertheless, during the inauguration of the laboratories, they came to review the safety standards and there were no negative comments on any problems. We also had a Workshop from CDC in our laboratories, and they congratulated us because of the facilities' biosecurity measures and the set of rules that our teachers and tutors enforce during lab sessions.
- Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?
- Many countries do not have proper biosafety protocols, and although many teams have not engaged potentially risky projects as the competition evolves and more BioBricks become available to future teams the challenges and hazards involved in the design of biomachines will surely increase; therefore this problem will gain even more significance. Preparedness is essential.
- Taking this into consideration, it would be useful or even necessary to create a committee of biosafety for the iGEM competition that regulates all the procedures in the laboratory and evaluate the possible risks that projects may implicate. This safety protocols could be developed by the iGEM community, discussed and proposed to be used by competing teams. The development of this idea could help every competing team that does not count with appropriate organisms or supervisors regarding this area.
- Biosafety engineering can contribute with the safety of parts, devices and systems if, in line with the interest of achieving a final product that reaches high quality standards, diverse procedures and practices were considered since their development in laboratories, for example those related with safety precautions, lab workers protection, assessment and managing, safe transportation of materials and substances, monitoring national/ international legislations, among others. It is relevant to consider the far-reaching concept of biosafety, which involves the use of tools and methods in order to guarantee a responsible use of biotechnology. Safety procedures must be included in every biotechnological development since its conception, so every person involved (enterprising people, regulatory organisms, and consumers), could acquire appropriate protocols. Biosafety engineering can be greatly helpful in the construction of safe projects, parts, devices and systems which will provide credibility, confidence; therefore the possibility of social acceptance and integration.
References:
-
- Tzotzos, G (1995). Genetically modified organisms: a guide to biosafety. International Centre for Genetic Engineering and Biotechnology, C.A.B. International
- Centers for Disease Control and Prevention (2011). Biosafety: Publications and Forms. Retrieved from: http://www.cdc.gov/biosafety/publications/index.htm
- World Health Organization (2011). International Health Regulations: Biosafety and Laboratory Security. Retrieved from: http://www.who.int/ihr/biosafety/en/
